Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

Atreca (BCEL)

Atreca Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BCEL
DateTimeSourceHeadlineSymbolCompany
10/05/202321:07Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BCELAtreca Inc
10/05/202321:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BCELAtreca Inc
10/05/202321:05GlobeNewswire Inc.Atreca Reports First Quarter 2023 Financial Results and Recent Corporate DevelopmentsNASDAQ:BCELAtreca Inc
01/05/202316:00Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:BCELAtreca Inc
27/04/202321:36Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:BCELAtreca Inc
27/04/202321:35Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:BCELAtreca Inc
26/04/202321:05GlobeNewswire Inc.Atreca Announces Oral Presentation of ATRC-101 Phase 1b Study Data at ASCO 2023 Annual MeetingNASDAQ:BCELAtreca Inc
13/04/202313:00GlobeNewswire Inc.Atreca to Participate in the Canaccord Genuity Horizons in Oncology Virtual ConferenceNASDAQ:BCELAtreca Inc
29/03/202322:24Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:BCELAtreca Inc
29/03/202321:11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BCELAtreca Inc
29/03/202321:05GlobeNewswire Inc.Atreca Reports Fourth Quarter and Full-Year 2022 Financial Results and ATRC-101 Data UpdateNASDAQ:BCELAtreca Inc
29/03/202321:02Edgar (US Regulatory)Annual Report (10-k)NASDAQ:BCELAtreca Inc
23/03/202321:00GlobeNewswire Inc.Atreca to Host Fourth Quarter and Year End 2022 Conference Call and Webcast on March 29, 2023NASDAQ:BCELAtreca Inc
01/03/202313:00GlobeNewswire Inc.Atreca to Participate at Cowen’s 43rd Annual Health Care ConferenceNASDAQ:BCELAtreca Inc
06/02/202313:00GlobeNewswire Inc.Atreca and Xencor to Develop T Cell Engaging Bispecific Antibody Directed Against Novel Solid Tumor TargetNASDAQ:BCELAtreca Inc
11/01/202323:45Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BCELAtreca Inc
11/01/202323:37Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:BCELAtreca Inc
09/01/202313:30GlobeNewswire Inc.Atreca Appoints Philippe Bishop, MD as Chief Medical OfficerNASDAQ:BCELAtreca Inc
07/12/202215:25Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BCELAtreca Inc
10/11/202221:35Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BCELAtreca Inc
10/11/202221:34Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BCELAtreca Inc
10/11/202221:30GlobeNewswire Inc.Atreca Reports Third Quarter 2022 Financial Results and Provides Pipeline UpdateNASDAQ:BCELAtreca Inc
07/11/202221:30GlobeNewswire Inc.Atreca to Present at Upcoming Investor ConferencesNASDAQ:BCELAtreca Inc
05/10/202221:05GlobeNewswire Inc.Atreca Announces Poster Presentations at Society for Immunotherapy of Cancer (SITC) Annual MeetingNASDAQ:BCELAtreca Inc
20/09/202223:14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BCELAtreca Inc
20/09/202223:13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BCELAtreca Inc
20/09/202223:12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BCELAtreca Inc
20/09/202223:11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BCELAtreca Inc
09/09/202221:05GlobeNewswire Inc.Atreca to Present at Upcoming Investor ConferencesNASDAQ:BCELAtreca Inc
29/08/202204:16TipRanksRobert W. Baird Sticks to Their Buy Rating for Atreca (BCEL)NASDAQ:BCELAtreca Inc
 Showing the most relevant articles for your search:NASDAQ:BCEL